Stockreport

Spyre Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]

Spyre Therapeutics, Inc.  (SYRE) 
PDF antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory Bowel Disease ("IBD") and other immune-mediated diseases [Read more]